Suppr超能文献

囊性纤维化中真菌的临床意义。

Clinical Relevance of Fungi in Cystic Fibrosis.

机构信息

Department of Education and Research, Health and Medical University-Health and Medical University Potsdam, Potsdam, Germany.

Division of Cystic Fibrosis, Cystic Fibrosis Center West Brandenburg, Postdam, Germany.

出版信息

Semin Respir Crit Care Med. 2023 Apr;44(2):252-259. doi: 10.1055/s-0042-1759882. Epub 2023 Feb 6.

Abstract

In cystic fibrosis, a new era has started with the approval and use of highly effective cystic fibrosis transport regulator (CFTR) modulator therapy. As pulmonary function is increasing and exacerbation rate significantly decreases, the current meaning of fungal pulmonary diseases is questioned. During the past couple of decades, several studies have been conducted regarding fungal colonization and infection of the airways in people with cystic fibrosis. Although for filamentous fungi and for yeasts remain by far the most common fungal species in patients with cystic fibrosis, the pattern of fungal species associated with cystic fibrosis has considerably diversified recently. Fungi such as or are recognized as pathogenic in cystic fibrosis and therefore need attention in clinical settings. In this article, current definitions are stated. Important diagnostic steps are described, and their usefulness discussed. Furthermore, clinical treatment strategies and recommendations are named and evaluated. In cystic fibrosis, fungal entities can be divided into different subgroups. Besides colonization, allergic bronchopulmonary aspergillosis, bronchitis, sensitization, pneumonia, and aspergilloma can occur as a fungal disease entity. For allergic bronchopulmonary aspergillosis, bronchitis, pneumonia, and aspergilloma, clear indications for therapy exist but this is not the case for sensitization or colonization. Different pulmonary fungal disease entities in people with cystic fibrosis will continue to occur also in an era of highly effective CFTR modulator therapy. Whether the percentage will decrease or not will be the task of future evaluations in studies and registry analysis. Using the established definition for different categories of fungal diseases is recommended and should be taken into account if patients are deteriorating without responding to antibiotic treatment. Drug-drug interactions, in particular when using azoles, should be recognized and therapies need to be adjusted accordingly.

摘要

在囊性纤维化中,随着高效囊性纤维化转运调节剂 (CFTR) 调节剂治疗的批准和使用,一个新时代已经开始。随着肺功能的增加和恶化率的显著降低,真菌性肺部疾病的当前意义受到质疑。在过去的几十年中,已经进行了几项关于囊性纤维化患者气道真菌定植和感染的研究。尽管 和 仍然是囊性纤维化患者最常见的真菌物种,但与囊性纤维化相关的真菌物种模式最近已经大大多样化。 和 等真菌被认为是囊性纤维化的病原体,因此在临床环境中需要注意。本文陈述了当前的定义。描述了重要的诊断步骤,并讨论了它们的有用性。此外,还命名和评估了临床治疗策略和建议。在囊性纤维化中,真菌实体可以分为不同的亚组。除了定植外,过敏性支气管曲霉病、支气管炎、致敏、肺炎和曲霉肿也可以作为真菌疾病实体发生。对于过敏性支气管曲霉病、支气管炎、肺炎和曲霉肿,存在明确的治疗指征,但对于致敏或定植则不然。在高效 CFTR 调节剂治疗时代,不同的肺部真菌疾病实体在囊性纤维化患者中仍将继续发生。未来的研究和登记分析将评估其百分比是否会减少。建议使用不同类别的真菌病的既定定义,如果患者在没有对抗生素治疗产生反应的情况下恶化,应考虑这些定义。应认识到药物-药物相互作用,特别是在使用唑类药物时,并相应调整治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验